﻿<?xml version="1.0" encoding="utf-8"?><?xml-stylesheet title="XSL_formatting" type="text/xsl" href="cms1260795.aspx"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><language>en-gb</language><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><lastBuildDate>Thu, 03 Jul 2008 23:49:37 GMT</lastBuildDate><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><description><![CDATA[aidsmap.com news feed : aidsmap news]]></description><copyright>Copyright NAM 2008</copyright><link>http://www.aidsmap.com</link><atom:link href="http://www.aidsmap.com/cms1260794.aspx" rel="self" type="application/rss+xml" /><image><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><url>http://www.aidsmap.com/files/file1002517.gif</url><link>http://www.aidsmap.com</link><width>122</width><height>44</height></image><ttl>15</ttl><item><title><![CDATA[Important changes to nevirapine dosing advice made by FDA]]></title><link>http://www.aidsmap.com/en/news/2985475A-5BBF-4687-A07F-1887EFC4505A.asp</link><author>Michael Carter</author><guid isPermaLink="false">2985475A-5BBF-4687-A07F-1887EFC4505A</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[Babies and children should receive doses of nevirapine (Viramune) according to their surface area rather than their weight, according to new prescribing advice issued by the US Food and Drug Administration (FDA). Other new prescribing advice includes a recommendation that the “lead-in” once daily dose period should not exceed 28 days, and firmer cautions about the use of nevirapine by patients with liver problems.
]]></description><category>Starting treatment news</category><category>Children and HIV news</category><category>Side-effects news</category></item><item><title><![CDATA[Fatty liver in patients with HIV associated with metabolic abnormalities]]></title><link>http://www.aidsmap.com/en/news/4B789DA4-50C9-4677-B0D1-1893872D174B.asp</link><author>Michael Carter</author><guid isPermaLink="false">4B789DA4-50C9-4677-B0D1-1893872D174B</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[Patients treated with antiretroviral therapy have a high prevalence of fatty liver disease, according to an Italian study published in the July 15th edition of the Journal of Infectious Diseases. The overall prevalence of the condition amongst individuals in the study was 37%. None of these individuals had hepatitis B or C infection, drank excessively or were drug users. 
]]></description><category>Lipodystrophy news</category></item><item><title><![CDATA[Most HIV infections in Zambia and Rwanda happen in marriage: prevention programmes for couples recommended]]></title><link>http://www.aidsmap.com/en/news/F1985DFF-1DAF-4DDA-A83A-6D10988BE00D.asp</link><author>Gus Cairns</author><guid isPermaLink="false">F1985DFF-1DAF-4DDA-A83A-6D10988BE00D</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[Mathematical modelling of Zambian and Rwandan populations, based on the rates of extramarital sex and the proportion of couples who are HIV-serodiscordant, shows that the proportion of HIV infections acquired in any one year that are acquired within marriage or in stable cohabiting relationships ranges from 55% to 93%.
]]></description><category>Africa news</category><category>Prevention news</category></item><item><title><![CDATA[HIV-positive Caribbean people in the UK experience high levels of stigma]]></title><link>http://www.aidsmap.com/en/news/E7FCEDC4-38A4-40BF-9D99-17A741D04B93.asp</link><author /><guid isPermaLink="false">E7FCEDC4-38A4-40BF-9D99-17A741D04B93</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[By Roger Pebody
]]></description><category>UK news</category></item><item><title><![CDATA[Poverty and unemployment common amongst HIV-positive Londoners]]></title><link>http://www.aidsmap.com/en/news/540BA09C-B63E-43AB-9EB3-CCB8F13CCDCF.asp</link><author>Michael Carter</author><guid isPermaLink="false">540BA09C-B63E-43AB-9EB3-CCB8F13CCDCF</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[Many people with HIV in London are unemployed and live in poverty, according to a study published in the online edition of HIV Medicine. The investigators found that levels of hardship were greatest amongst HIV-positive individuals who were migrants or from ethnic minorities, but that significant numbers of white gay men were also unemployed or reported not having enough money to live on.
]]></description><category>UK news</category></item><item><title><![CDATA[Risk of death for people with HIV now similar to that seen in the general population]]></title><link>http://www.aidsmap.com/en/news/723532B1-93C1-4D62-B608-361F340BAAB8.asp</link><author>Michael Carter</author><guid isPermaLink="false">723532B1-93C1-4D62-B608-361F340BAAB8</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[Thanks to improving anti-HIV treatment, people with HIV, in the first five years after diagnosis with HIV, now have mortality rates similar to those seen in the general population, according to a large European study published in the July 2nd edition of the Journal of the American Medical Associations. 
]]></description><category>Statistics and epidemiology news</category><category>Developed world news</category></item><item><title><![CDATA[Simple, cheap test an accurate measure of hardening of the arteries in patients with HIV]]></title><link>http://www.aidsmap.com/en/news/65B6F014-52A1-4CC7-9A40-9B4CD4C3AD42.asp</link><author>Michael Carter</author><guid isPermaLink="false">65B6F014-52A1-4CC7-9A40-9B4CD4C3AD42</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[A simple and cheap test to measure hardening of the arteries appears to be effective in HIV-positive patients, according to a study published in the July 11th edition of AIDS. Investigators in Spain found that a low ankle-brachial index (ABI) in patients with HIV was correlated with carotid intima-media thickness (IMT), a traditional measure of hardening of the arteries, or atherosclerosis.
]]></description><category>Lipodystrophy news</category><category>Medical tests news</category></item><item><title><![CDATA[Asymptomatic anal HPV infection more common than thought in heterosexual men]]></title><link>http://www.aidsmap.com/en/news/9F3DE0A7-8F84-4D0D-A57A-C900EC1BAA8C.asp</link><author>Kelly Morris</author><guid isPermaLink="false">9F3DE0A7-8F84-4D0D-A57A-C900EC1BAA8C</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[Anal infection with human papilloma virus (HPV) is more prevalent in heterosexual men than previously thought, according to a US study published in the June 15th edition of the Journal of Infectious Diseases.
]]></description><category>HIV and cancer news</category><category>HIV and sexual health news</category></item><item><title><![CDATA[Rapid rises in diagnoses in US gay men concentrated in black and younger men]]></title><link>http://www.aidsmap.com/en/news/C24E6EC1-F223-4613-9C97-F8DB5D1AAED5.asp</link><author /><guid isPermaLink="false">C24E6EC1-F223-4613-9C97-F8DB5D1AAED5</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[By Roger Pebody
]]></description><category>Prevention news</category><category>Gay men news</category></item><item><title><![CDATA[Antiretroviral use increases survival sixfold in Thai patients with HIV and tuberculosis]]></title><link>http://www.aidsmap.com/en/news/CB33F04A-5D30-4FC1-B416-CB3212F6FEEB.asp</link><author>Derek Thaczuk</author><guid isPermaLink="false">CB33F04A-5D30-4FC1-B416-CB3212F6FEEB</guid><pubDate>Thu, 03 Jul 2008 23:49:37 GMT</pubDate><image /><description><![CDATA[In Thailand, people co-infected with HIV and tuberculosis who receive antiretroviral therapy are six times as likely to survive as those who do not, according to a study reported in the June 1st issue of the Journal of Acquired Immune Deficiency Syndromes. These results are drawn from one of the first large-scale studies to control for confounding factors which may have influenced estimates of survival benefit in this population.
]]></description><category>Starting treatment news</category><category>Asia and Pacific news</category><category>Tuberculosis news</category></item></channel></rss>